A structural MRI study of cholinergic pathways and cognition in multiple sclerosis

Peyser, 1990, Guidelines for neuropsychological research in multiple sclerosis, Arch. Neurol., 47, 94, 10.1001/archneur.1990.00530010120030 Rao, 1991, Cognitive dysfunction in multiple sclerosis: frequency, patterns, and predictions, Neurology, 41, 685, 10.1212/WNL.41.5.685 Benedict, 2006, Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS), J. Int. Neuropsychol. Soc., 12, 549, 10.1017/S1355617706060723 Drachman, 1974, Human memory and the cholinergic system. A relationship to aging?, Arch. Neurol., 30, 113, 10.1001/archneur.1974.00490320001001 Everitt, 1997, Central cholinergic systems and cognition, Annu. Rev. Psychol., 48, 649, 10.1146/annurev.psych.48.1.649 Selden, 1998, Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain, Brain, 121, 2249, 10.1093/brain/121.12.2249 Bocti, 2005, A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia, Stroke, 36, 2126, 10.1161/01.STR.0000183615.07936.b6 Behl, 2007, Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients, Arch. Neurol., 64, 266, 10.1001/archneur.64.2.266 Kim, 2013, Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia, J. Alzheimers Dis., 35, 129, 10.3233/JAD-122320 Lim, 2014, Cortical hubs and subcortical cholinergic pathways as neural substrates of poststroke dementia, Stroke, 45, 1069, 10.1161/STROKEAHA.113.004156 Shin, 2012, Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status, J. Neurol. Neurosurg. Psychiatry, 83, 315, 10.1136/jnnp-2011-300872 Sunwoo, 2014, The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease, Eur. J. Neurol., 21, 922, 10.1111/ene.12412 Park, 2015, Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism, J. Neurol. Sci., 353, 44, 10.1016/j.jns.2015.03.046 Rajji, 2012, Cholinergic pathways and cognition in patients with schizophrenia: a pilot study, Schizophr. Res., 139, 46, 10.1016/j.schres.2012.06.006 Chamelian, 2005, Detecting cognitive dysfunction in multiple sclerosis with a magnetic resonance imaging rating scale: a pilot study, CNS Spectr., 10, 394, 10.1017/S1092852900022768 Virta, 2011, Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment, Mult. Scler., 17, 931, 10.1177/1352458511399613 Kooi, 2011, Cholinergic imbalance in the multiple sclerosis hippocampus, Acta Neuropathol., 122, 313, 10.1007/s00401-011-0849-4 Christodoulou, 2008, Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?, CNS Drugs, 22, 87, 10.2165/00023210-200822020-00001 Polman, 2011, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann. Neurol., 69, 292, 10.1002/ana.22366 Folstein, 1975, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 Fujiwara, 2010, Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment, Geriatr Gerontol Int, 10, 225, 10.1111/j.1447-0594.2010.00585.x Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444 Schmidt, 2012, An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis, NeuroImage, 59, 3774, 10.1016/j.neuroimage.2011.11.032 Yaldizli, 2014, The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients, Mult. Scler., 20, 356, 10.1177/1352458513496880 Granberg, 2015, Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: results of a 17-year longitudinal study, Mult. Scler., 21, 1151, 10.1177/1352458514560928 Fulton, 1999, MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis, AJNR Am. J. Neuroradiol., 20, 1951 Filippi, 2010, The contribution of MRI in assessing cognitive impairment in multiple sclerosis, Neurology, 75, 2121, 10.1212/WNL.0b013e318200d768 Iyo, 1997, Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease, Lancet, 349, 1805, 10.1016/S0140-6736(96)09124-6 Rinne, 2003, Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease, J. Neurol. Neurosurg. Psychiatry, 74, 113, 10.1136/jnnp.74.1.113 Bohnen, 2009, Cholinergic denervation occurs early in Parkinson disease, Neurology, 73, 256, 10.1212/WNL.0b013e3181b0bd3d Marshall, 2006, White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia, Acta Neurol. Scand., 113, 87, 10.1111/j.1600-0404.2005.00553.x Shimada, 2009, Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET, Neurology, 73, 273, 10.1212/WNL.0b013e3181ab2b58 Bohnen, 2009, Age-associated leukoaraiosis and cortical cholinergic deafferentation, Neurology, 72, 1411, 10.1212/WNL.0b013e3181a187c6 Sternberg, 2016, Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies, Autoimmun. Rev., 15, 113, 10.1016/j.autrev.2015.04.012 Mäurer, 2013, Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients, Mult. Scler., 19, 631, 10.1177/1352458512463481 Yamauchi, 2000, Corpus callosum atrophy in patients with leukoaraiosis may indicate global cognitive impairment, Stroke, 31, 1515, 10.1161/01.STR.31.7.1515 Ryberg, 2008, White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study, AJNR Am. J. Neuroradiol., 29, 1498, 10.3174/ajnr.A1169 Huijbregts, 2004, Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS, Neurology, 63, 335, 10.1212/01.WNL.0000129828.03714.90 Denney, 2005, Cognitive impairment in three subtypes of multiple sclerosis, Arch. Clin. Neuropsychol., 20, 967, 10.1016/j.acn.2005.04.012 Huijbregts, 2006, Cognitive impairment and decline in different MS subtypes, J. Neurol. Sci., 245, 187, 10.1016/j.jns.2005.07.018